Skip to main content
Clinical Trials/CTRI/2019/06/019741
CTRI/2019/06/019741
Not yet recruiting
Phase 3

A prospective controlled clinical study to assess the efficacy of shadabindu tail nasya in management of keshachyutee (hair fall)

Minal sagar pawar0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Sponsor
Minal sagar pawar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Minal sagar pawar

Eligibility Criteria

Inclusion Criteria

  • All the patients clinically diagnosed for hair fall last more than 3 months.
  • Patients ready to give written consent.

Exclusion Criteria

  • Genetic inheritance for hair fall.
  • k/o hypothyroidism and hyperthyroidism.
  • Patients associated with major illness.
  • Patient undergoing modern medicine treatment/any other treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials